Canada Pension Plan Investment Board Aptinyx Inc. Transaction History

Canada Pension Plan Investment Board

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$3.05 - $4.99 $381,250 - $623,750	-125,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.99 - $4.4 $248,750 - $550,000	125,000 New	125,000 $521,000
Q3 2019 Nov 12, 2019	SELL	$3.0 - $4.08 $150,000 - $204,000	-50,000 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$2.95 - $4.38 $147,500 - $219,000	-50,000 Reduced 50.0%	50,000 $167,000
Q1 2019 May 15, 2019	BUY	$3.99 - $19.33 $399,000 - $1.93 Million	100,000 New	100,000 $405,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.